Table 3. Controlled ovarian hyperstimulation regimens.
Study	Type of protocol	Dual trigger group	hCG group
Schachter et al., 2008	Antagonist	hMG + Cetrorelix	HMG + Cetrorelix
Kim et al., 2014	Antagonist	150-225 UI rFSH + Cetrorelix	150-225 UI rFSH + Cetrorelix
Decleer et al., 2014	Antagonist	200 UI rFSH + Ganirelix	200 UI rFSH + Ganirelix
Mahajan et al., 2016	Antagonist	FSH + hMH-HP + Cetrorelix	FSH + hMH-HP + Cetrorelix
Maged et al., 2021	Antagonist	300 UI r-FSH + 150 UI LH+FSH + Cetrorelix	300 UI r-FSH + 150 UI LH+FSH + Cetrorelix
Haas et al., 2020	Antagonist	150-225 UI r-FSH + Ganirelix	150-225 UI r-FSH + Ganirelix